Nationwide Fund Advisors’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-12,755
| Closed | -$142K | – | 2678 |
|
|
2017
Q3 | $142K | Hold |
12,755
| – | – | ﹤0.01% | 2770 |
|
|
2017
Q2 | $117K | Buy |
12,755
+855
| +7% | +$7.84K | ﹤0.01% | 2843 |
|
|
2017
Q1 | $102K | Buy |
11,900
+858
| +8% | +$7.35K | ﹤0.01% | 2837 |
|
|
2016
Q4 | $118K | Hold |
11,042
| – | – | ﹤0.01% | 2818 |
|
|
2016
Q3 | $120K | Sell |
11,042
-11,353
| -51% | -$123K | ﹤0.01% | 2830 |
|
|
2016
Q2 | $152K | Buy |
22,395
+8,670
| +63% | +$58.8K | ﹤0.01% | 2745 |
|
|
2016
Q1 | $93K | Buy |
13,725
+3,540
| +35% | +$24K | ﹤0.01% | 2853 |
|
|
2015
Q4 | $64K | Hold |
10,185
| – | – | ﹤0.01% | 2955 |
|
|
2015
Q3 | $90K | Hold |
10,185
| – | – | ﹤0.01% | 2925 |
|
|
2015
Q2 | $120K | Sell |
10,185
-21,789
| -68% | -$257K | ﹤0.01% | 2965 |
|
|
2015
Q1 | $463K | Buy |
31,974
+23,006
| +257% | +$333K | ﹤0.01% | 2277 |
|
|
2014
Q4 | $153K | Hold |
8,968
| – | – | ﹤0.01% | 2767 |
|
|
2014
Q3 | $112K | Buy |
8,968
+170
| +2% | +$2.12K | ﹤0.01% | 2944 |
|
|
2014
Q2 | $129K | Buy |
8,798
+1,331
| +18% | +$19.5K | ﹤0.01% | 2944 |
|
|
2014
Q1 | $152K | Hold |
7,467
| – | – | ﹤0.01% | 2606 |
|
|
2013
Q4 | $146K | Buy |
7,467
+170
| +2% | +$3.32K | ﹤0.01% | 2825 |
|
|
2013
Q3 | $330K | Buy |
7,297
+4,368
| +149% | +$198K | ﹤0.01% | 2428 |
|
|
2013
Q2 | $70K | Buy |
+2,929
| New | +$70K | ﹤0.01% | 2897 |
|